Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$118.15
al cierre: Oct 7 EDT
$118.15
0.000.00%
Pre-comercialización: 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Visteon Corp ha un obiettivo di prezzo di consenso pari a $132.3, stabilito in base alle ultime valutazioni degli analisti di 24. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, B of A Securities y Guggenheim il septiembre 25, 2025, septiembre 10, 2025 y septiembre 9, 2025. Con un obiettivo di prezzo medio di $144.67 tra le Wells Fargo, B of A Securities y Guggenheim, c'è un implicito 22.44% upside per Visteon Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
B of A Securities
Guggenheim
Morgan Stanley
JP Morgan
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Visteon
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/25/2025 | 27.8% | Wells Fargo | $145 → $151 | Maintains | Overweight | |||
09/10/2025 | 18.49% | B of A Securities | $130 → $140 | Maintains | Buy | |||
09/09/2025 | 21.03% | Guggenheim | $134 → $143 | Maintains | Buy | |||
09/09/2025 | 22.73% | Wells Fargo | $129 → $145 | Maintains | Overweight | |||
08/12/2025 | -19.59% | Morgan Stanley | $90 → $95 | Maintains | Equal-Weight | |||
07/28/2025 | -11.98% | JP Morgan | $101 → $104 | Maintains | Neutral | |||
07/25/2025 | 1.57% | Barclays | $115 → $120 | Maintains | Equal-Weight | |||
07/25/2025 | 23.57% | UBS | $142 → $146 | Maintains | Buy | |||
07/25/2025 | 9.18% | Wells Fargo | $106 → $129 | Maintains | Overweight | |||
07/25/2025 | 10.88% | Deutsche Bank | $120 → $131 | Maintains | Buy | |||
07/21/2025 | -14.52% | JP Morgan | $97 → $101 | Maintains | Neutral | |||
07/16/2025 | -2.67% | Barclays | $95 → $115 | Maintains | Equal-Weight | |||
07/14/2025 | 20.19% | UBS | $85 → $142 | Upgrade | Neutral → Buy | |||
07/11/2025 | 1.57% | Goldman Sachs | $83 → $120 | Upgrade | Neutral → Buy | |||
07/11/2025 | 5.8% | Baird | $96 → $125 | Upgrade | Neutral → Outperform | |||
07/02/2025 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
07/01/2025 | -10.28% | Wells Fargo | $101 → $106 | Maintains | Overweight | |||
05/19/2025 | -23.83% | Morgan Stanley | $95 → $90 | Maintains | Equal-Weight | |||
05/19/2025 | -14.52% | Wells Fargo | $96 → $101 | Maintains | Overweight | |||
05/05/2025 | -17.9% | JP Morgan | $90 → $97 | Maintains | Neutral | |||
04/28/2025 | -18.75% | Wells Fargo | $101 → $96 | Maintains | Overweight | |||
04/25/2025 | -27.21% | Baird | $76 → $86 | Maintains | Neutral | |||
04/22/2025 | -22.98% | Guggenheim | $108 → $91 | Maintains | Buy | |||
04/15/2025 | -35.67% | Baird | $100 → $76 | Maintains | Neutral | |||
04/15/2025 | -30.6% | Barclays | $110 → $82 | Downgrade | Overweight → Equal-Weight | |||
04/10/2025 | -35.67% | UBS | $114 → $76 | Downgrade | Buy → Neutral | |||
04/10/2025 | -37.37% | Goldman Sachs | $103 → $74 | Downgrade | Buy → Neutral | |||
04/07/2025 | -14.52% | Wells Fargo | $124 → $101 | Maintains | Overweight | |||
03/03/2025 | -19.59% | Morgan Stanley | $100 → $95 | Maintains | Equal-Weight | |||
03/03/2025 | -6.9% | Barclays | $115 → $110 | Maintains | Overweight | |||
02/19/2025 | -15.36% | RBC Capital | $127 → $100 | Maintains | Outperform | |||
02/19/2025 | 4.95% | Wells Fargo | $119 → $124 | Maintains | Overweight | |||
01/24/2025 | 7.49% | RBC Capital | $124 → $127 | Maintains | Outperform | |||
01/22/2025 | -2.67% | Barclays | $140 → $115 | Maintains | Overweight | |||
12/16/2024 | 0.72% | Wells Fargo | $122 → $119 | Maintains | Overweight | |||
10/25/2024 | 4.95% | RBC Capital | $129 → $124 | Maintains | Outperform | |||
10/21/2024 | 3.26% | JP Morgan | $132 → $122 | Maintains | Neutral | |||
10/15/2024 | 18.49% | Barclays | $145 → $140 | Maintains | Overweight | |||
10/01/2024 | -0.97% | Goldman Sachs | $130 → $117 | Maintains | Buy | |||
09/20/2024 | 3.26% | Wells Fargo | $115 → $122 | Upgrade | Equal-Weight → Overweight | |||
09/10/2024 | 4.95% | Deutsche Bank | → $124 | Reinstates | → Buy | |||
09/05/2024 | — | Wolfe Research | — | Assumes | → Peer Perform | |||
08/22/2024 | 9.18% | RBC Capital | $144 → $129 | Maintains | Outperform | |||
08/14/2024 | -15.36% | Morgan Stanley | $135 → $100 | Maintains | Equal-Weight | |||
07/26/2024 | 18.49% | TD Cowen | $142 → $140 | Maintains | Buy | |||
07/26/2024 | -2.67% | Wells Fargo | $107 → $115 | Maintains | Equal-Weight | |||
07/22/2024 | 14.26% | JP Morgan | $144 → $135 | Maintains | Neutral | |||
07/12/2024 | 6.64% | Citigroup | $139 → $126 | Maintains | Buy | |||
07/12/2024 | 1.57% | Baird | $137 → $120 | Downgrade | Outperform → Neutral | |||
07/10/2024 | 12.57% | Goldman Sachs | $161 → $133 | Maintains | Buy | |||
07/10/2024 | 14.26% | UBS | $144 → $135 | Maintains | Buy | |||
06/25/2024 | -9.44% | Wells Fargo | $108 → $107 | Maintains | Equal-Weight | |||
05/10/2024 | 14.26% | Morgan Stanley | $145 → $135 | Maintains | Equal-Weight | |||
04/26/2024 | 15.95% | Baird | $140 → $137 | Maintains | Outperform | |||
04/26/2024 | -8.59% | Wells Fargo | $106 → $108 | Upgrade | Underweight → Equal-Weight | |||
04/22/2024 | 22.73% | JP Morgan | $146 → $145 | Maintains | Neutral | |||
04/17/2024 | 6.64% | Guggenheim | $136 → $126 | Maintains | Buy | |||
04/10/2024 | 22.73% | Barclays | $140 → $145 | Upgrade | Equal-Weight → Overweight | |||
03/07/2024 | 23.57% | RBC Capital | $188 → $146 | Maintains | Outperform | |||
02/29/2024 | 35.42% | B of A Securities | $165 → $160 | Maintains | Buy | |||
02/21/2024 | -10.28% | Wells Fargo | $101 → $106 | Maintains | Underweight | |||
01/25/2024 | 25.26% | JP Morgan | $160 → $148 | Maintains | Neutral | |||
01/24/2024 | 18.49% | Barclays | $158 → $140 | Maintains | Equal-Weight | |||
01/17/2024 | 22.73% | UBS | $143 → $145 | Upgrade | Neutral → Buy | |||
01/11/2024 | 58.27% | RBC Capital | $187 → $187 | Reiterates | Outperform → Outperform | |||
01/04/2024 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
12/13/2023 | 10.03% | Exane BNP Paribas | → $130 | Downgrade | Outperform → Neutral | |||
11/06/2023 | 26.11% | Citigroup | → $149 | Upgrade | Neutral → Buy | |||
10/27/2023 | 21.03% | UBS | $146 → $143 | Maintains | Neutral | |||
10/12/2023 | — | Barclays | — | Upgrade | Underweight → Equal-Weight | |||
10/11/2023 | 26.11% | Citigroup | $160 → $149 | Maintains | Neutral | |||
10/10/2023 | 23.57% | UBS | $157 → $146 | Maintains | Neutral | |||
10/03/2023 | 4.1% | Wells Fargo | $138 → $123 | Maintains | Underweight | |||
09/26/2023 | 52.35% | B of A Securities | → $180 | Reinstates | → Buy | |||
09/13/2023 | 32.88% | UBS | → $157 | Initiates | → Neutral | |||
08/07/2023 | 14.26% | Barclays | $130 → $135 | Maintains | Underweight | |||
08/04/2023 | 54.04% | RBC Capital | $184 → $182 | Maintains | Outperform | |||
08/04/2023 | 16.8% | Wells Fargo | $130 → $138 | Maintains | Underweight | |||
07/20/2023 | 32.88% | JP Morgan | $156 → $157 | Maintains | Neutral | |||
07/18/2023 | 35.42% | Citigroup | $159 → $160 | Maintains | Neutral | |||
07/10/2023 | 10.03% | Wells Fargo | $127 → $130 | Maintains | Underweight | |||
06/08/2023 | 48.12% | Wolfe Research | → $175 | Upgrade | Peer Perform → Outperform | |||
05/17/2023 | 36.27% | Guggenheim | → $161 | Upgrade | Neutral → Buy | |||
05/01/2023 | 34.57% | Citigroup | $165 → $159 | Maintains | Neutral | |||
04/28/2023 | 7.49% | Wells Fargo | $126 → $127 | Maintains | Underweight | |||
04/17/2023 | 10.03% | Barclays | $135 → $130 | Maintains | Underweight | |||
04/10/2023 | 6.64% | Wells Fargo | $125 → $126 | Maintains | Underweight | |||
03/14/2023 | 39.65% | Citigroup | $145 → $165 | Maintains | Neutral | |||
03/09/2023 | 22.73% | Morgan Stanley | $135 → $145 | Maintains | Equal-Weight | |||
03/08/2023 | 55.73% | RBC Capital | $169 → $184 | Maintains | Outperform | |||
02/21/2023 | 14.26% | Morgan Stanley | $115 → $135 | Maintains | Equal-Weight | |||
02/17/2023 | 5.8% | Wells Fargo | $102 → $125 | Maintains | Underweight | |||
02/17/2023 | 52.35% | Goldman Sachs | $160 → $180 | Maintains | Buy | |||
02/17/2023 | 43.88% | Baird | $163 → $170 | Maintains | Outperform | |||
02/17/2023 | — | Guggenheim | — | Downgrade | Buy → Neutral | |||
02/15/2023 | 5.8% | Barclays | → $125 | Initiates | → Underweight | |||
01/17/2023 | -13.67% | Wells Fargo | $101 → $102 | Maintains | Underweight | |||
01/13/2023 | 22.73% | Citigroup | $129 → $145 | Maintains | Neutral | |||
10/28/2022 | -2.67% | Morgan Stanley | $107 → $115 | Maintains | Equal-Weight | |||
10/28/2022 | 36.27% | RBC Capital | $153 → $161 | Maintains | Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Visteon (VC)?
El último precio objetivo de Visteon (NASDAQ:VC) fue comunicado por Wells Fargo el septiembre 25, 2025. La firma de analistas fijó un precio objetivo para $151.00 que espera VC a rise dentro de 12 meses (un posible 27.80% upside). 38 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Visteon (VC)?
La última calificación de analistas para Visteon (NASDAQ:VC) fue proporcionada por Wells Fargo, y Visteon mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Visteon (VC)?
La última revisión al alza de Visteon Corp se produjo en julio 14, 2025, cuando UBS elevó su precio objetivo a $142. UBS anteriormente tenía a neutral para Visteon Corp.
¿Cuándo fue la última revisión a la baja de Visteon (VC)?
La última revisión a la baja de Visteon Corp se produjo en abril 15, 2025, cuando Barclays cambió su precio objetivo de $110 a $82 para Visteon Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Visteon (VC)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Visteon, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Visteon se registró el septiembre 25, 2025, por lo que la próxima calificación estará disponible en torno al septiembre 25, 2026.
¿Es correcta la calificación de los analistas sobre Visteon (VC)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Visteon (VC) fue un mantuvo con un precio objetivo de $145.00 a $151.00. El precio actual al que cotiza Visteon (VC) es de $118.15, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.